Thursday, May 8, 2018, 12-130 PM. Details are available at LLS.org/programs
Presented by:
Matthew S. Davids, MD, MMSc
Assistant Professor of Medicine, Harvard Medical School
Director, Lymphoma BioBank
Associate Director, CLL Center
Dana-Farber Cancer Institute
Boston, MA
PAN Foundation has Reopened its CLL (chronic lymphocytic leukemia) Financial Assistance Fund
Webinar on CLL treatment - a Changing Landscape
FDA Approves Zanubrutinib for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphom
ASH 2017: Dr. Richard Furman on the importance of MCL-1 in CLL (chronic lymphocytic leukemia)Chronic lymphocytic leukemia/B-cell prolymphocytic leukemia. A tutorial for physicians, useful for us too.
